Your browser doesn't support javascript.
loading
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.
Hammel, Pascal; Huguet, Florence; van Laethem, Jean-Luc; Goldstein, David; Glimelius, Bengt; Artru, Pascal; Borbath, Ivan; Bouché, Olivier; Shannon, Jenny; André, Thierry; Mineur, Laurent; Chibaudel, Benoist; Bonnetain, Franck; Louvet, Christophe.
Afiliação
  • Hammel P; Department of Digestive Oncology, Beaujon Hospital (AP-HP), Clichy, France.
  • Huguet F; Department of Radiotherapy, Tenon Hospital (AP-HP), Paris, France.
  • van Laethem JL; Department of Gastroenterology, Erasme University Hospital, Brussels, Belgium.
  • Goldstein D; Department of Medical Oncology, Prince of Wales Hospital, Sydney, Australia5Australasian Gastrointestinal Trials Group (AGITG), Camperdown, Australia6Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.
  • Glimelius B; Department of Radiology, Oncology, and Radiation Science, University of Uppsala, Uppsala, Sweden.
  • Artru P; Department of Gastroenterology, Jean Mermoz Hospital, Lyon, France.
  • Borbath I; Department of Gastroenterology, Saint-Luc University Clinics, Brussels, Belgium.
  • Bouché O; Department of Gastroenterology, Robert Debré Hospital, Reims, France.
  • Shannon J; Australasian Gastrointestinal Trials Group (AGITG), Camperdown, Australia6Prince of Wales Clinical School, University of New South Wales, Sydney, Australia11Department of Medical Oncology, Nepean Hospital NSW, Sydney, Australia.
  • André T; Department of Medical Oncology, Saint-Antoine Hospital (AP-HP), Paris, France.
  • Mineur L; Department of Radiotherapy and Medical Oncology, Sainte-Catherine Institute, Avignon, France.
  • Chibaudel B; Department of Medical Oncology, Franco-British Hospital Institute, Levallois-Perret, France15Oncology Multidisciplinary Research Group (GERCOR), Paris, France.
  • Bonnetain F; Department of Methodology and Quality of Life in Oncology, Hospital Minjoz, Besançon, France.
  • Louvet C; Department of Medical Oncology, Institute Mutualiste Montsouris, Paris, France.
JAMA ; 315(17): 1844-53, 2016 May 03.
Article em En | MEDLINE | ID: mdl-27139057
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Desoxicitidina / Quimiorradioterapia / Cloridrato de Erlotinib / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Desoxicitidina / Quimiorradioterapia / Cloridrato de Erlotinib / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França